These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24083670)

  • 41. Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China.
    Huang L; Zou J; Zhang Y; Gu J; Wu J; Zhang C
    BMJ Open; 2024 Mar; 14(3):e075138. PubMed ID: 38490657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSC
    Ghazavi H; Hoseini SJ; Ebrahimzadeh-Bideskan A; Mashkani B; Mehri S; Ghorbani A; Sadri K; Mahdipour E; Ghasemi F; Forouzanfar F; Hoseini A; Pasdar AR; Sadeghnia HR; Ghayour-Mobarhan M
    Stem Cell Rev Rep; 2017 Oct; 13(5):670-685. PubMed ID: 28795363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury.
    Yu X; Lu C; Liu H; Rao S; Cai J; Liu S; Kriegel AJ; Greene AS; Liang M; Ding X
    PLoS One; 2013; 8(5):e62703. PubMed ID: 23671625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms.
    Toyoshima A; Yasuhara T; Kameda M; Morimoto J; Takeuchi H; Wang F; Sasaki T; Sasada S; Shinko A; Wakamori T; Okazaki M; Kondo A; Agari T; Borlongan CV; Date I
    PLoS One; 2015; 10(6):e0127302. PubMed ID: 26075717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke.
    Nagpal A; Kremer KL; Hamilton-Bruce MA; Kaidonis X; Milton AG; Levi C; Shi S; Carey L; Hillier S; Rose M; Zacest A; Takhar P; Koblar SA
    Int J Stroke; 2016 Jul; 11(5):575-85. PubMed ID: 27030504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis.
    Lamo-Espinosa JM; Blanco JF; Sánchez M; Moreno V; Granero-Moltó F; Sánchez-Guijo F; Crespo-Cullel Í; Mora G; San Vicente DD; Pompei-Fernández O; Aquerreta JD; Núñez-Córdoba JM; Vitoria Sola M; Valentí-Azcárate A; Andreu EJ; Del Consuelo Del Cañizo M; Valentí-Nin JR; Prósper F
    J Transl Med; 2020 Sep; 18(1):356. PubMed ID: 32948200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke.
    Gutiérrez-Fernández M; Rodríguez-Frutos B; Ramos-Cejudo J; Teresa Vallejo-Cremades M; Fuentes B; Cerdán S; Díez-Tejedor E
    Stem Cell Res Ther; 2013 Jan; 4(1):11. PubMed ID: 23356495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and efficacy.
    Law ZK; Tan HJ; Chin SP; Wong CY; Wan Yahya WNN; Muda AS; Zakaria R; Ariff MI; Ismail NA; Cheong SK; S Abdul Wahid SF; Mohamed Ibrahim N
    Cytotherapy; 2021 Sep; 23(9):833-840. PubMed ID: 33992536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
    Connick P; Kolappan M; Crawley C; Webber DJ; Patani R; Michell AW; Du MQ; Luan SL; Altmann DR; Thompson AJ; Compston A; Scott MA; Miller DH; Chandran S
    Lancet Neurol; 2012 Feb; 11(2):150-6. PubMed ID: 22236384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
    Kaushal S; Wehman B; Pietris N; Naughton C; Bentzen SM; Bigham G; Mishra R; Sharma S; Vricella L; Everett AD; Deatrick KB; Huang S; Mehta H; Ravekes WA; Hibino N; Difede DL; Khan A; Hare JM
    Am Heart J; 2017 Oct; 192():48-56. PubMed ID: 28938963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.
    Harris VK; Stark J; Vyshkina T; Blackshear L; Joo G; Stefanova V; Sara G; Sadiq SA
    EBioMedicine; 2018 Mar; 29():23-30. PubMed ID: 29449193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preconditioning with interleukin-1 alpha is required for the neuroprotective properties of mesenchymal stem cells after ischemic stroke in mice.
    Wong R; Smith CJ; Allan SM; Pinteaux E
    J Cereb Blood Flow Metab; 2023 Dec; 43(12):2040-2048. PubMed ID: 37602422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.
    Mohamadnejad M; Alimoghaddam K; Bagheri M; Ashrafi M; Abdollahzadeh L; Akhlaghpoor S; Bashtar M; Ghavamzadeh A; Malekzadeh R
    Liver Int; 2013 Nov; 33(10):1490-6. PubMed ID: 23763455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesenchymal Stem Cell Therapy for Ischemic Stroke.
    Toyoshima A; Yasuhara T; Date I
    Acta Med Okayama; 2017 Aug; 71(4):263-268. PubMed ID: 28824181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autologous mesenchymal stem cell transplantation in stroke patients.
    Bang OY; Lee JS; Lee PH; Lee G
    Ann Neurol; 2005 Jun; 57(6):874-82. PubMed ID: 15929052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review.
    Behzadifard M; Aboutaleb N; Dolatshahi M; Khorramizadeh M; Mirshekari Jahangiri H; Kord Z; Nazarinia D
    Neurochem Res; 2023 May; 48(5):1280-1292. PubMed ID: 36581731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
    J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential.
    Li J; Zhang Q; Wang W; Lin F; Wang S; Zhao J
    J Neurol; 2021 Nov; 268(11):4095-4107. PubMed ID: 32761505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Autologous Expanded Bone Marrow Mesenchymal Stem Cells or Leukocyte-Poor Platelet-Rich Plasma in Chronic Patellar Tendinopathy (With Gap >3 mm): Preliminary Outcomes After 6 Months of a Double-Blind, Randomized, Prospective Study.
    Rodas G; Soler-Rich R; Rius-Tarruella J; Alomar X; Balius R; Orozco L; Masci L; Maffulli N
    Am J Sports Med; 2021 May; 49(6):1492-1504. PubMed ID: 33783227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.